Background: Antenatal magnesium sulphate, widely used in obstetrics to improve maternal and infant outcomes, may be associated with adverse effects for the mother sufficient for treatment cessation.
In view of the extremely widespread use of antenatal magnesium sulphate in obstetric practice, in this systematic review we aimed to quantify the extent of maternal adverse effects attributed to ...
Magnesium sulfate 500mg/mL; soln for IM inj; or IV use after dilution; contains aluminum. Mild deficiency: 1g IM every 6 hours for four doses. Severe deficiency: 250mg/kg IM within a period of 4 ...